LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

Home・Aktien・Essa Pharma Inc

Essa Pharma Inc

Geschlossen

0.19 -5

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.16

Max

0.2

Schlüsselkennzahlen
By Trading Economics
Einkommen	2.4M -4M
EPS	-0.14
Dividendenrendite	87.56
Gewinnspanne	-4,681.422
Angestellte	35
EBITDA	1.4M -5M

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	87.56% 3.12%

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-73M 11M
Vorheriger Eröffnungskurs	5.19
Vorheriger Schlusskurs	0.19

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

1.7 / 1.72 Unterstützung & Widerstand

Essa Pharma Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

15. Sept. 2025, 22:39 UTC

Akquisitionen, Fusionen, Übernahmen

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15. Sept. 2025, 16:43 UTC

Wichtige Markttreiber

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15. Sept. 2025, 16:42 UTC

Wichtige Markttreiber

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15. Sept. 2025, 16:35 UTC

Wichtige Markttreiber

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15. Sept. 2025, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15. Sept. 2025, 23:46 UTC

Market Talk

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15. Sept. 2025, 23:34 UTC

Market Talk

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15. Sept. 2025, 22:48 UTC

Market Talk

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15. Sept. 2025, 22:12 UTC

Akquisitionen, Fusionen, Übernahmen

CSL Expects Commercial Launch in 2029

15. Sept. 2025, 22:12 UTC

Akquisitionen, Fusionen, Übernahmen

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15. Sept. 2025, 22:11 UTC

Akquisitionen, Fusionen, Übernahmen

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15. Sept. 2025, 22:11 UTC

Akquisitionen, Fusionen, Übernahmen

CSL to Have Right to Exercise Option Based on Phase 3 Data

15. Sept. 2025, 22:10 UTC

Akquisitionen, Fusionen, Übernahmen

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15. Sept. 2025, 21:16 UTC

Akquisitionen, Fusionen, Übernahmen

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15. Sept. 2025, 21:16 UTC

Akquisitionen, Fusionen, Übernahmen

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15. Sept. 2025, 21:15 UTC

Akquisitionen, Fusionen, Übernahmen

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15. Sept. 2025, 21:14 UTC

Akquisitionen, Fusionen, Übernahmen

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15. Sept. 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15. Sept. 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

15. Sept. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15. Sept. 2025, 19:29 UTC

Market Talk

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15. Sept. 2025, 19:14 UTC

Market Talk

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15. Sept. 2025, 18:16 UTC

Market Talk

Gold Powers to New High -- Market Talk

15. Sept. 2025, 18:05 UTC

Market Talk

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15. Sept. 2025, 17:50 UTC

Akquisitionen, Fusionen, Übernahmen

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15. Sept. 2025, 17:10 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15. Sept. 2025, 17:10 UTC

Market Talk

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15. Sept. 2025, 16:52 UTC

Market Talk

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15. Sept. 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

15. Sept. 2025, 16:20 UTC

Market Talk

Ergebnisse

Auto & Transport Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Essa Pharma Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Essa Pharma Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

1.7 / 1.72Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Essa Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.